07.21.22
In the second quarter of 2022, Essity’s net sales increased 30.9% to SEK 37.9 billion ($3.7 billion). Sales growth, including organic sales growth and acquisitions, amounted to 20.6%. Organic sales growth, which excludes exchange rate effects, acquisitions and divestments, amounted to 17.8%, of which volume accounted for 3.7% and price/mix for 14.1%. Organic sales growth in mature markets amounted to 19.2% and in emerging markets to 16%. Emerging markets accounted for 38% of net sales. Exchange rate effects increased net sales by 10.4%. Acquisitions increased net sales by 2.8%. Divestments reduced net sales by 0.1%.
“In a turbulent world, Essity stands strong,” says Magnus Groth President and CEO. “We have further strengthened the company through significant price increases, successful product launches, increased productivity and leading sustainability work. In July, we announced the acquisition of two companies in leakproof apparel to become the fastest growing company in Intimate Hygiene.”
In the Consumer Goods segment, Q2 net sales increased 30.7% to SEK 22.97 billion ($2.2 billion). Sales growth, including organic sales growth and acquisitions, amounted to 20%. Organic sales growth amounted to 17.9%, of which volume accounted for 1.3% and price/mix for 16.6%. Organic sales growth amounted to 19.7% in mature markets. In emerging markets, which accounted for 50% of net sales, organic sales growth was 16.1%. Exchange rate effects increased net sales by 10.7%. Acquisitions increased net sales by 2.1%.
For Incontinence Products Retail, organic sales growth amounted to 12.5%, in Feminine Care to 17.7% and in Baby Care to 2.1%. For these three categories, prices were higher and volumes higher in Incontinence Products Retail and Feminine Care. The discontinuation of baby diaper operations in Latin America had a negative impact on growth in Baby Care. In Consumer Tissue, organic sales growth amounted to 21.6% and for the Consumer Tissue Private Label Europe division to 31.7%. The sales growth was mainly the result of price increases but volumes were also higher.
In the Health & Medical segment, Q2 net sales increased 16.9% to SEK 6.1 billion ($596 million). Sales growth, including organic sales growth and acquisitions, amounted to 10.9%. Organic sales growth amounted to 7.9%, of which volume accounted for 3.9% and price/mix for 4.0%. The organic sales growth amounted to 6.0% in mature markets. In emerging markets, which accounted for 21% of net sales, organic sales growth was 15.4%. Exchange rate effects increased net sales by 6.4%. Acquisitions increased net sales by 3.0%. Divestments reduced net sales by 0.4%.
For Incontinence Products Health Care, organic sales growth amounted to 7.5% due to higher volumes and higher prices. In Medical Solutions, organic sales growth amounted to 8.5% mainly as a result of higher volumes and higher prices. Sales growth was high in Wound Care and Orthopedics.
“In a turbulent world, Essity stands strong,” says Magnus Groth President and CEO. “We have further strengthened the company through significant price increases, successful product launches, increased productivity and leading sustainability work. In July, we announced the acquisition of two companies in leakproof apparel to become the fastest growing company in Intimate Hygiene.”
In the Consumer Goods segment, Q2 net sales increased 30.7% to SEK 22.97 billion ($2.2 billion). Sales growth, including organic sales growth and acquisitions, amounted to 20%. Organic sales growth amounted to 17.9%, of which volume accounted for 1.3% and price/mix for 16.6%. Organic sales growth amounted to 19.7% in mature markets. In emerging markets, which accounted for 50% of net sales, organic sales growth was 16.1%. Exchange rate effects increased net sales by 10.7%. Acquisitions increased net sales by 2.1%.
For Incontinence Products Retail, organic sales growth amounted to 12.5%, in Feminine Care to 17.7% and in Baby Care to 2.1%. For these three categories, prices were higher and volumes higher in Incontinence Products Retail and Feminine Care. The discontinuation of baby diaper operations in Latin America had a negative impact on growth in Baby Care. In Consumer Tissue, organic sales growth amounted to 21.6% and for the Consumer Tissue Private Label Europe division to 31.7%. The sales growth was mainly the result of price increases but volumes were also higher.
In the Health & Medical segment, Q2 net sales increased 16.9% to SEK 6.1 billion ($596 million). Sales growth, including organic sales growth and acquisitions, amounted to 10.9%. Organic sales growth amounted to 7.9%, of which volume accounted for 3.9% and price/mix for 4.0%. The organic sales growth amounted to 6.0% in mature markets. In emerging markets, which accounted for 21% of net sales, organic sales growth was 15.4%. Exchange rate effects increased net sales by 6.4%. Acquisitions increased net sales by 3.0%. Divestments reduced net sales by 0.4%.
For Incontinence Products Health Care, organic sales growth amounted to 7.5% due to higher volumes and higher prices. In Medical Solutions, organic sales growth amounted to 8.5% mainly as a result of higher volumes and higher prices. Sales growth was high in Wound Care and Orthopedics.